Who owns Aclaris Therapeutics?
- Ticker: ACRS
- CUSIP Number: 00461u105
Tip: Access positions for across all investors
Analyze quarterly positions in Aclaris Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aclaris Therapeutics stock
Who bought or sold Aclaris Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 14M | $53M | 0% | Mar 2026 |
|
| Deep Track Capital | 9.3M | $35M | 100% | Mar 2026 |
|
| BlackRock | 7.4M | $28M | 9% | Mar 2026 |
|
| RA Capital Management | 6.8M | $26M | 100% | Mar 2026 |
|
| Vivo Capital | 6.7M | $25M | -25% | Mar 2026 |
|
| Vanguard Capital Management | 5.2M | $19M | 100% | Mar 2026 |
|
| Frazier Life Sciences Management | 4.9M | $19M | 100% | Mar 2026 |
|
| Rock Springs Capital Management | 4.5M | $17M | 0% | Mar 2026 |
|
| Decheng Capital | 4.0M | $15M | 0% | Mar 2026 |
|
| Adage Capital Partners GP | 3.9M | $15M | 15% | Mar 2026 |
|
| Balyasny Asset Management | 3.4M | $13M | 100% | Mar 2026 |
|
| Citadel Advisors | 2.8M | $11M | 20% | Mar 2026 |
|
| Morgan Stanley | 2.7M | $10M | -20% | Mar 2026 |
|
| Geode Capital Management | 2.4M | $9.1M | 1% | Mar 2026 |
|
| State Street Corporation | 2.0M | $7.5M | 33% | Mar 2026 |
|
| Kalehua Capital Management | 1.8M | $6.9M | 100% | Mar 2026 |
|
| Braidwell | 1.7M | $6.4M | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 1.7M | $6.2M | 100% | Mar 2026 |
|
| Palo Alto Investors | 1.6M | $6.1M | 3% | Mar 2026 |
|
| Acadian Asset Management | 1.5M | $5.8M | -27% | Mar 2026 |
|
| Woodline Partners | 1.5M | $5.6M | 100% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 1.4M | $5.3M | -1% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 998k | $3.7M | 1% | Mar 2026 |
|
| Aldebaran Capital | 947k | $3.6M | -1% | Mar 2026 |
|
| D. E. Shaw & Co | 901k | $3.4M | -57% | Mar 2026 |
|
| Millennium Management | 756k | $2.8M | -28% | Mar 2026 |
|
| Northern Trust | 728k | $2.7M | 10% | Mar 2026 |
|
| Three Bridge Wealth Advisors | 715k | $2.7M | 0% | Mar 2026 |
|
| Marshall Wace | 713k | $2.7M | 47% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 629k | $2.4M | 100% | Mar 2026 |
|
| Susquehanna International | 600k | $2.3M | -35% | Mar 2026 |
|
| Goldman Sachs Group | 589k | $2.2M | -7% | Mar 2026 |
|
| Dimensional Fund Advisors | 512k | $1.9M | 89% | Mar 2026 |
|
| Renaissance Technologies | 503k | $1.9M | -55% | Mar 2026 |
|
| PanAgora Asset Management | 502k | $1.9M | 637% | Mar 2026 |
|
| Monashee Investment Management | 500k | $1.9M | 100% | Mar 2026 |
|
| Logos Global Management | 500k | $1.9M | -17% | Mar 2026 |
|
| Aisling Capital Management | 435k | $1.6M | 0% | Mar 2026 |
|
| Bollard | 432k | $1.6M | -46% | Mar 2026 |
|
| Two Sigma Investments | 396k | $1.5M | -31% | Mar 2026 |
|
| MPM Oncology Impact Management | 392k | $1.5M | 100% | Mar 2026 |
|
| Superstring Capital Management | 367k | $1.4M | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 330k | $1.2M | 0% | Mar 2026 |
|
| Russell Investments | 308k | $1.2M | 3049% | Mar 2026 |
|
| HighTower Advisors | 306k | $1.1M | 0% | Mar 2026 |
|
| Raymond James Financial | 266k | $999k | -1% | Mar 2026 |
|
| Charles Schwab Investment Management | 261k | $979k | -8% | Mar 2026 |
|
| Wellington Management Company | 257k | $964k | -3% | Mar 2026 |
|
| Sei Investments | 217k | $814k | 100% | Mar 2026 |
|
| Invesco | 215k | $806k | 2% | Mar 2026 |
|
| Mackenzie Financial | 213k | $800k | 100% | Mar 2026 |
|
| Bank of New York Mellon | 207k | $776k | 2% | Mar 2026 |
|
| UBS Group | 207k | $776k | -43% | Mar 2026 |
|
| Verdad Advisers | 197k | $739k | 100% | Mar 2026 |
|
| Qube Research & Technologies | 195k | $729k | -57% | Mar 2026 |
|
| Eudaimonia Asset Management | 178k | $669k | 100% | Mar 2026 |
|
| FMR | 176k | $661k | 285% | Mar 2026 |
|
| Assenagon Asset Management | 155k | $818k | -13% | Jun 2026 |
|
| Creative Planning | 152k | $570k | 197% | Mar 2026 |
|
| ADAR1 Capital Management | 132k | $497k | -78% | Mar 2026 |
|
| American Century Companies | 119k | $445k | 53% | Mar 2026 |
|
| Nuveen | 118k | $443k | -50% | Mar 2026 |
|
| ALPS Advisors | 98k | $368k | 10% | Mar 2026 |
|
| XTX Topco | 98k | $367k | -13% | Mar 2026 |
|
| Jane Street | 92k | $346k | 239% | Mar 2026 |
|
| Bank of America Corporation | 80k | $298k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 75k | $283k | 5% | Mar 2026 |
|
| Quadrature Capital | 73k | $272k | 26% | Mar 2026 |
|
| AQR Capital Management | 72k | $272k | -30% | Mar 2026 |
|
| Vanguard Global Advisers | 69k | $258k | 100% | Mar 2026 |
|
| CenterBook Partners | 67k | $250k | 100% | Mar 2026 |
|
| Diversified Trust Company | 46k | $241k | 55% | Jun 2026 |
|
| MetLife Investment Advisors | 44k | $165k | 71% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 44k | $164k | 2% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 42k | $157k | 0% | Mar 2026 |
|
| Susquehanna Portfolio Strategies | 40k | $149k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 36k | $136k | -65% | Mar 2026 |
|
| EntryPoint Capital | 33k | $124k | 100% | Mar 2026 |
|
| New York State Common Retirement Fund | 27k | $102k | 0% | Mar 2026 |
|
| SG Americas Securities | 27k | $100k | 74% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 25k | $95k | -12% | Mar 2026 |
|
| Vontobel Holding | 25k | $94k | -4% | Mar 2026 |
|
| Two Sigma Securities | 23k | $84k | 95% | Mar 2026 |
|
| Neuberger Berman Group | 22k | $83k | 16% | Mar 2026 |
|
| Barclays | 22k | $81k | -85% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 21k | $80k | 0% | Mar 2026 |
|
| China Universal Asset Management | 21k | $80k | 21% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 20k | $74k | 0% | Mar 2026 |
|
| Intech Investment Management | 19k | $72k | -59% | Mar 2026 |
|
| ProShare Advisors | 19k | $70k | -13% | Mar 2026 |
|
| Engineers Gate Manager | 18k | $69k | 100% | Mar 2026 |
|
| CRA Financial Services | 18k | $67k | 0% | Mar 2026 |
|
| JustInvest | 18k | $66k | 100% | Mar 2026 |
|
| CIBC Global Asset Management | 17k | $65k | 0% | Mar 2026 |
|
| Hudson Bay Capital Management | 17k | $63k | 100% | Mar 2026 |
|
| Ing Investment Management | 16k | $61k | -5% | Mar 2026 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 16k | $60k | 100% | Mar 2026 |
|
| Alliancebernstein | 15k | $46k | 0% | Mar 2026 |
|
| Prudential Financial | 13k | $50k | 100% | Mar 2026 |
|
| Victory Capital Management | 12k | $44k | 10% | Mar 2026 |
|
| Simplex Trading | 11k | $42k | -33% | Mar 2026 |
|
| Leucadia National Corporation | 11k | $41k | 0% | Mar 2026 |
|
| Mercer Global Advisors | 11k | $40k | 4% | Mar 2026 |
|
| M^T Bank Corporation | 10k | $38k | 100% | Mar 2026 |
|
| Summit Investment Advisors | 9.3k | $35k | 0% | Mar 2026 |
|
| Legal & General Group | 8.2k | $31k | 0% | Mar 2026 |
|
| Citigroup | 7.8k | $29k | 100% | Mar 2026 |
|
| Mirae Asset Global Investments | 6.3k | $24k | 19% | Mar 2026 |
|
| Rockefeller Capital Management | 6.1k | $23k | 399% | Mar 2026 |
|
| Zurcher Kantonalbank | 5.0k | $19k | 100% | Mar 2026 |
|
| California State Teachers Retirement System | 5.0k | $19k | -12% | Mar 2026 |
|
| Tower Research Capital | 3.9k | $15k | 3% | Mar 2026 |
|
| MBM Wealth Consultants | 3.2k | $12k | 100% | Mar 2026 |
|
| Sterling Capital Management | 3.0k | $11k | -43% | Mar 2026 |
|
| Gf Fund Management | 2.4k | $9.1k | 14% | Mar 2026 |
|
| Pnc Financial Services | 2.1k | $7.8k | 0% | Mar 2026 |
|
| CWM | 1.4k | $5.1k | 257% | Mar 2026 |
|
| Farther Finance Advisors | 1.2k | $6.2k | 239% | Jun 2026 |
|
| GAMMA Investing | 1.0k | $5.4k | 0% | Jun 2026 |
|
| Northwestern Mutual Wealth Management Company | 500.00 | $1.9k | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 477.00 | $1.8k | 4% | Mar 2026 |
|
| Capital Advisors | 454.00 | $2.0k | 0% | Jun 2026 |
|
| Massmutual Trust | 391.00 | $2.1k | 100% | Jun 2026 |
|
| Smartleaf Asset Management | 376.00 | $1.3k | 0% | Mar 2026 |
|
| Parallel Advisors | 357.00 | $1.3k | 100% | Mar 2026 |
|
| NISA Investment Advisors | 318.00 | $1.2k | 0% | Mar 2026 |
|
| Cornerstone Financial Management | 270.00 | $1.0k | 100% | Mar 2026 |
|
| Truvestments Capital | 150.00 | $562.995000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 88.00 | $0 | 100% | Mar 2026 |
|
| SBI Securities | 67.00 | $251.002100 | -15% | Mar 2026 |
|
| Hanson McClain Advisors | 49.00 | $183.999900 | 100% | Mar 2026 |
|
| Root Financial Partners | 27.00 | $100.998900 | 100% | Mar 2026 |
|
| Rothschild Investment | 9.00 | $34.000200 | 12% | Mar 2026 |
|
| Essential Partners | 5.00 | $19.000000 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 1.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Aclaris Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ameriprise Financial | Dec 2025 | 318k | $959k |
| Two Sigma Advisers | Dec 2025 | 255k | $769k |
| Seven Fleet Capital Management | Dec 2025 | 107k | $323k |
| Point72 Asset Management | Dec 2025 | 87k | $262k |
| Man Group | Dec 2025 | 42k | $128k |
| Axq Capital | Dec 2025 | 24k | $73k |
| Persistent Asset Partners | Dec 2025 | 22k | $67k |
| Mariner Wealth Advisors | Dec 2025 | 17k | $50k |
| Group One Trading | Dec 2025 | 12k | $37k |
| R Squared | Dec 2025 | 12k | $37k |
| Amalgamated Bank | Dec 2025 | 2.9k | $9.0k |
| Advisor Group Holdings | Dec 2025 | 730.00 | $2.2k |
| SRS Capital Advisors | Dec 2025 | 19.00 | $57.000000 |